Targeted Release of Probiotics from Enteric Microparticulated Formulations
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
The development of advanced probiotic delivery systems, which preserve bacteria from degradation of the gastrointestinal tract and achieve a targeted release mediated by pH-independent swelling, is of great interest to improve the efficient delivery of probiotic bacteria to the target tissue. Gram-positive and Gram-negative bacteria models (Lactobacillus acidophilus (Moro) Hansen and Mocquot (ATCC® 4356™) and Escherichia coli S17, respectively) have been successfully encapsulated for the first time in pH-independent microparticulate polymethacrylates (i.e., Eudraguard biotic) used for the targeted delivery of nutraceuticals to the colon. These bacteria have also been encapsulated within the mucoadhesive polymethacrylate Eudragit RS 100 widely used as targeted release formulation for active pharmaceutical ingredients. The enteric microparticles remained unaltered under simulated gastric conditions and released the contained viable microbial cargo under simulated intestinal conditions. Buoyancies of 90.2% and 57.3% for Eudragit and Eudraguard microparticles, respectively, and long-term stability (5 months) for the encapsulated microorganisms were found. Cytotoxicity of the microparticles formulated with both polymers was evaluated (0.5–20 mg/mL) on Caco-2 cells, showing high cytocompatibility. These results underline the suitability of the synthesized materials for the successful delivery of probiotic formulations to the target organ, highlighting for the first time the potential use of Eudraguard biotic as an effective enteric coating for the targeted delivery of probiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Technological advances including microencapsulation and cryoprotectants could improve the stability of future LBP formulations90,91, and buffering may be considered to preserve cell activity and viability in the stomach.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of solute release from porous hydrophilic polymers
Korsmeyer, R. W., Gurny, R., Doelker, E., Buri, P., & Peppas, N. A. (1983) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(83)90064-9 · Cited by 5,258
Higuchi, T. (1963) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600521210 · Cited by 4,884
Surviving the Acid Test: Responses of Gram-Positive Bacteria to Low pH
Cotter, P. D., & Hill, C. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.3.429-453.2003 · Cited by 1,379
Korsmeyer, R. W., Gurny, R., Doelker, E., Buri, P., & Peppas, N. A. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600721021 · Cited by 776
Ford, A. C., Quigley, E. M. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Moayyedi, P. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.202 · Cited by 747
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review
Moayyedi, P., Ford, A. C., Talley, N. J., Cremonini, F., Foxx-Orenstein, A. E., Brandt, L. J., & Quigley, E. M. M. (2010) · Gut · doi:10.1136/gut.2008.167270 · Cited by 728
High internal phase emulsions (HIPEs) — Structure, properties and use in polymer preparation
Cameron, N. R., & Sherrington, D. C. (1996) · Advances in Polymer Science · doi:10.1007/3-540-60484-7_4 · Cited by 454
Incorporation of bifidobacteria into cheeses: challenges and rewards
Boylston, T. D., Vinderola, C. G., Ghoddusi, H. B., & Reinheimer, J. A. (2004) · International Dairy Journal · doi:10.1016/j.idairyj.2003.08.008 · Cited by 363
Didari, T. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i10.3072 · Cited by 356
Pharmaceutical significance of Eudragit: A review
Patra, C. N., Priya, R., Swain, S., Kumar Jena, G., Panigrahi, K. C., & Ghose, D. (2017) · Future Journal of Pharmaceutical Sciences · doi:10.1016/j.fjps.2017.02.001 · Cited by 295
Cited by
Developing a new class of engineered live bacterial therapeutics to treat human diseases
Charbonneau, M. R., Isabella, V. M., Li, N., & Kurtz, C. B. (2020) · Nature Communications · doi:10.1038/s41467-020-15508-1 · Cited by 523
On‐Demand Bacterial Reactivation by Restraining within a Triggerable Nanocoating
Feng, P., Cao, Z., Wang, X., Li, J., & Liu, J. (2020) · Advanced Materials · doi:10.1002/adma.202002406 · Cited by 189
Recent developments in probiotics: An emphasis on Bifidobacterium
Sharma, M., Wasan, A., & Sharma, R. K. (2021) · Food Bioscience · doi:10.1016/j.fbio.2021.100993 · Cited by 163
Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation
Kvaková, M., Bertková, I., Štofilová, J., & Savidge, T. (2021) · Foods · doi:10.3390/foods10061297 · Cited by 115
Miranda-Calderon, L., Yus, C., Ganuza, C. R. D., Paesa, M., Landa, G., Tapia, E., Pérez, E., Pérez, M. M., Sebastián, V., Irusta, S., et al. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.146679 · Cited by 89
Self-citation
Metadata
- Authors
- Yus, C., Gracia, R., Larrea, A., Andreu, V., Irusta, S., Sebastian, V., Mendoza, G., & Arruebo, M.
- Affiliations
- Universidad de Zaragoza (ES)
- Department of Chemical Engineering, Aragón Institute of Nanoscience (INA), University of Zaragoza, Campus Río Ebro-Edificio I+D, C/ Poeta Mariano Esquillor S/N, 50018-Zaragoza, Spain
- Corresponding author
- Mendoza, Gracia
- ORCID
- Venue
- Polymers
- Publisher
- MDPI AG
- Published
- 2019-10-13
- Volume
- 11
- Issue
- 10
- Pages
- 1668
- ISSN
- 2073-4360 (ISSN-L)
- PMC
- PMC6835770
- OpenAlex
- W2980164103
- Cited by
- 47
- References
- 44
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 4 · 2023: 8 · 2022: 8 · 2021: 5 · 2020: 7
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Polymers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (acceptedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (acceptedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Zaguan (University of Zaragoza Repository) (submittedVersion, cc-by)
- Funders
- European Research Council (ERC‐2013‐CoG‐614715, NANOHEDONISM)
- Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Agricultural and Biological Sciences › Food Science › Microencapsulation and Drying Processes
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- probiotic delivery, Eudragit RS100, Lactobacillus acidophilus, colon-targeted drug delivery, simulated gastrointestinal conditions, buoyancy, probiotic viability, cytocompatibility, Caco-2 cells, mucoadhesive polymers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.